Thought Leadership
Many CEOs and Boards make one or more significant mistakes during early biotech funding rounds. Discover three of the most common mistakes and crucial mitigation strategies you can take.
Purpose and Motivation The Board of Advisors has a narrower, less central role than the other components of your firm’s leadership. However, where your Directors and executives are integral to every aspect of company function, advisors should be relied on to fill specific, well-defined knowledge gaps and do so in particular problem-solving contexts. Advisors may,…
Less than 10% of leadership roles in biotech are held by women. Learn from the women in biotech leadership roles and their accomplishments.
Talent retention and talent attraction are major concerns in our current landscape. As such, hybrid or remote work can be a strategy to use.
Executive hiring should be gender-neutral, with clear inequities between female and male leaders, we must ask if quotas are the answer to solving gender diversity in the workplace.
The Five-Generation Workplace Biotech is an ever-evolving industry. It is one of the most innovative, inventive, and adaptive industries globally, alongside finance and applied tech. Talent competition is fierce, and at the moment, turnover is exceptionally high. This is forcing companies to adapt to attract and retain the best talent. Thanks to increasing life expectancy…
Psychedelics have had a hard time finding their way to commercial markets. Starting in the 1970s, cultural and political pressure led to the cancellation of most serious studies, and as recently as 2015 the BMJ was writing that legal restrictions were “making [medical] trials almost impossible.”
Although the US and Canada typically top lists for clinical trials destinations, Europe still remains one of the most important regions. When it comes to early trials, the UK still leads Europe.
During the early stages of research, conceptualization, and then incorporation, biotech founders are under intense pressure to form a high-profile Board of Directors capable of attracting attention and successfully leading fundraising.
As we continue to navigate COVID-19, many of the biggest names in pharma and biotech are experiencing staffing shortages and hiring challenges brought on by the global pandemic.